GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer - Concepedia

Concepedia

Publication | Open Access

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer

DOI Full Paper Access

17

Citations

12

References

2024

Year

Rachel N. Grisham, Bradley J. Monk, Els Van Nieuwenhuysen, Kathleen N. Moore, Michel Fabbro, David M. O’Malley, Ana Oaknin, Premal H. Thaker, Amit M Oza, Nicoletta Colombo,

International Journal of Gynecological Cancer

Abstract

ClinicalTrials.gov NCT06072781.

References

	Year	Citations

Page 1